Laura Sepp-Lorenzino, EVP, Chief Scientific Officer at Intellia Therapeutics, Inc. (NTLA), sold 17,932 shares at $12.18 ($218K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $218k NTLA by EVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.18 | 8,966 | $109K | 50.0% |
| 2 | $12.18 | 8,966 | $109K | 50.0% |
| Total | $12.18 avg | 17,932 | $218K | 100% |
| Filing → |
| NTLA | SELL | 2023-01-06 | $339K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $129K | — | Filing → |
| NTLA | SELL | 2021-09-01 | $30.0M | — | Filing → |